BIOR

Biora Therapeutics Inc
4.57
-0.20 (-4.19%)
Company Name Stock Ticker Symbol Market Type
Biora Therapeutics Inc BIOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -4.19% 4.57 19:59:47
Open Price Low Price High Price Close Price Prev Close
4.77 4.38 5.25 4.40 4.77
more quote information »

Recent News

Date Time Source Heading
1/27/202317:02EDGARSecurities Registration Statement (simplified Form) (s-3)
1/20/202316:07EDGARCurrent Report Filing (8-k)
1/19/202316:05GLOBEBiora Therapeutics Presents Data from Device Performance..
1/12/202316:47EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/12/202306:29EDGARCurrent Report Filing (8-k)
1/11/202316:29DJNBiora Up Another 26% as Volume Tops 54.3M Shares
1/09/202316:03EDGARCurrent Report Filing (8-k)
1/09/202309:00GLOBEBiora Therapeutics Receives Pre-IND Feedback from FDA and..
1/05/202316:07EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:07EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:06EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:06EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:06EDGARStatement of Changes in Beneficial Ownership (4)
12/30/202209:02EDGARCurrent Report Filing (8-k)
12/30/202209:00GLOBEBiora Therapeutics Announces Reverse Stock Split
12/09/202217:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/08/202216:05GLOBEBiora Therapeutics Announces Two Poster Presentations at the..
11/29/202209:00GLOBEBiora Therapeutics Licenses Preeclampsia Rule-Out Test for..
11/23/202216:07EDGARCurrent Report Filing (8-k)
11/18/202216:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/15/202206:25TRMNBiora Therapeutics (BIOR) Gets a Buy from H.C. Wainwright
11/14/202217:53EDGARCurrent Report Filing (8-k)
11/14/202216:50EDGARStatement of Changes in Beneficial Ownership (4)
11/14/202216:01GLOBEBiora Therapeutics Provides Corporate Update..
11/10/202217:06EDGARProxy Statement - Notice of Shareholders Meeting..
11/10/202216:09EDGARCurrent Report Filing (8-k)
11/09/202206:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/07/202216:15GLOBEBiora Therapeutics to Report Third Quarter 2022 Financial..
11/07/202208:06GLOBEBiora Therapeutics Announces $9.75 Million Direct Offering
11/07/202206:10EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/27/202209:00GLOBEBiora Therapeutics Announces Sale of Cell-Free DNA Patent..
10/25/202209:00GLOBEBiora Therapeutics Shares Data from Device Performance Study..
10/24/202209:00GLOBEBiora Therapeutics Shares Five Posters Presented at American..
10/19/202209:00GLOBEBiora Therapeutics Shares Preclinical Data on Oral Delivery..
10/10/202209:00GLOBEBiora Therapeutics to Participate in 12th Annual Partnership..
9/13/202209:00GLOBEBiora Therapeutics Announces Issuance of Key Patent for Oral..
9/07/202209:00GLOBEBiora Therapeutics Appoints Dr. Bruce Sands as Chair of its..
9/06/202206:30GLOBEBiora Therapeutics to Participate in Upcoming H.C...
8/16/202218:03EDGARStatement of Changes in Beneficial Ownership (4)
8/16/202217:59EDGARStatement of Changes in Beneficial Ownership (4)
8/16/202206:16TRMNH.C. Wainwright Sticks to Their Buy Rating for Biora..
8/15/202216:22EDGARCurrent Report Filing (8-k)
8/15/202216:05GLOBEBiora Therapeutics Provides Corporate Update..
8/10/202209:00GLOBEBiora Therapeutics Announces Successful Completion of Device..
8/08/202209:00GLOBEBiora Therapeutics to Report Second Quarter 2022 Financial..
8/03/202209:00GLOBEBiora Therapeutics Announces Five Abstracts Accepted at..
7/26/202209:00GLOBEBiora Therapeutics to Participate in Upcoming BTIG..
7/14/202212:05TRMNBiora Therapeutics (BIOR) Gets a Buy Rating from H.C...
7/14/202209:00GLOBEBiora Therapeutics Shares Preclinical Data on Oral Delivery..
7/07/202209:00GLOBEBiora Therapeutics Announces Successful Completion of Second..